Stocksigma LogoStocksigma Logo

Astal Laboratories Reports Zero Deviation in Fund Utilization for September 2026 Quarter

Astal Laboratories reported nil deviation or variation in the utilization of funds raised for the quarter ended 30th Sep'26, following review by its Audit

Astal Laboratories Reports Zero Deviation in Fund Utilization for September 2026 Quarter

Astal Laboratories Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 1:37 am

Astal Laboratories Reports Zero Deviation in Fund Utilization for September 2026 Quarter Astal Laboratories reported nil deviation or variation in the utilization of funds raised for the quarter ended 30th Sep'26, following review by its Audit Committee and Board on 13th Nov'26. The company fully utilized the total proceeds of Rs 33.99 Lakhs raised on 25th May'26 toward its designated long-term objectives, encompassing capital expenditure, working capital, and general corporate purposes to support ongoing business growth.

Original exchange filing (PDF)

More announcements from Astal Laboratories Ltd

All Astal Laboratories Ltd announcements